UBA6
Ubiquitin-like modifier-activating enzyme 6
Also known as: FLJ10808, UBA6_HUMAN, UBE1L2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A0AVT1
- Gene
- UBA6
- Ensembl
- ENSG00000033178
- Chromosome
- 4
- Canonical length
- 1052 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Modification of proteins with ubiquitin (UBB; MIM 191339) or ubiquitin-like proteins controls many signaling networks and requires a ubiquitin-activating enzyme (E1), a ubiquitin conjugating enzyme (E2), and a ubiquitin protein ligase (E3). UBE1L2 is an E1 enzyme that initiates the activation and conjugation of ubiquitin-like proteins (Jin et al., 2007 [PubMed 17597759]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
1052 residues, UniProt reviewed canonical sequence.
>A0AVT1|UBA6
1 MEGSEPVAAH QGEEASCSSW GTGSTNKNLP IMSTASVEID DALYSRQRYV LGDTAMQKMA
61 KSHVFLSGMG GLGLEIAKNL VLAGIKAVTI HDTEKCQAWD LGTNFFLSED DVVNKRNRAE
121 AVLKHIAELN PYVHVTSSSV PFNETTDLSF LDKYQCVVLT EMKLPLQKKI NDFCRSQCPP
181 IKFISADVHG IWSRLFCDFG DEFEVLDTTG EEPKEIFISN ITQANPGIVT CLENHPHKLE
241 TGQFLTFREI NGMTGLNGSI QQITVISPFS FSIGDTTELE PYLHGGIAVQ VKTPKTVFFE
301 SLERQLKHPK CLIVDFSNPE APLEIHTAML ALDQFQEKYS RKPNVGCQQD SEELLKLATS
361 ISETLEEKPD VNADIVHWLS WTAQGFLSPL AAAVGGVASQ EVLKAVTGKF SPLCQWLYLE
421 AADIVESLGK PECEEFLPRG DRYDALRACI GDTLCQKLQN LNIFLVGCGA IGCEMLKNFA
481 LLGVGTSKEK GMITVTDPDL IEKSNLNRQF LFRPHHIQKP KSYTAADATL KINSQIKIDA
541 HLNKVCPTTE TIYNDEFYTK QDVIITALDN VEARRYVDSR CLANLRPLLD SGTMGTKGHT
601 EVIVPHLTES YNSHRDPPEE EIPFCTLKSF PAAIEHTIQW ARDKFESSFS HKPSLFNKFW
661 QTYSSAEEVL QKIQSGHSLE GCFQVIKLLS RRPRNWSQCV ELARLKFEKY FNHKALQLLH
721 CFPLDIRLKD GSLFWQSPKR PPSPIKFDLN EPLHLSFLQN AAKLYATVYC IPFAEEDLSA
781 DALLNILSEV KIQEFKPSNK VVQTDETARK PDHVPISSED ERNAIFQLEK AILSNEATKS
841 DLQMAVLSFE KDDDHNGHID FITAASNLRA KMYSIEPADR FKTKRIAGKI IPAIATTTAT
901 VSGLVALEMI KVTGGYPFEA YKNCFLNLAI PIVVFTETTE VRKTKIRNGI SFTIWDRWTV
961 HGKEDFTLLD FINAVKEKYG IEPTMVVQGV KMLYVPVMPG HAKRLKLTMH KLVKPTTEKK
1021 YVDLTVSFAP DIDGDEDLPG PPVRYYFSHD TDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against UBA6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 16 nTPM
- retina: 13 nTPM
- tonsil: 13 nTPM
- lymph node: 12 nTPM
- pituitary gland: 11 nTPM
- esophagus: 11 nTPM
Single-cell type
- esophageal apical cells: 274 nCPM
- lactotrophs: 239 nCPM
- thyrotrophs: 236 nCPM
- somatotrophs: 220 nCPM
- neutrophil progenitors: 216 nCPM
- gonadotrophs: 212 nCPM
Immune cell
- basophil: 6.5 nTPM
- NK-cell: 5.8 nTPM
- memory CD8 T-cell: 3.2 nTPM
- memory B-cell: 3.1 nTPM
- plasmacytoid DC: 3.1 nTPM
- naive B-cell: 3 nTPM
Brain region
- white matter: 45 nTPM
- medulla oblongata: 35 nTPM
- thalamus: 33 nTPM
- spinal cord: 31 nTPM
- midbrain: 31 nTPM
- hypothalamus: 30 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.1
- DepMap mean gene effect
- -0.41
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- ATP binding
- metal ion binding
- ubiquitin activating enzyme activity
- FAT10 activating enzyme activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ubiquitin/SUMO-activating enzyme E1-like
- THIF-type NAD/FAD binding fold
- Ubiquitin-activating enzyme E1
- Ubiquitin-activating enzyme E1, C-terminal
- Ubiquitin-activating enzyme, SCCH domain
- Ubiquitin-activating enzyme E1, FCCH domain
- Ubiquitin-activating enzyme E1, four-helix bundle
- Ubiquitin-activating enzyme-like
- Ubiquitin-activating enzyme E1, C-terminal domain superfamily
- Ubiquitin-activating enzyme E1, SCCH domain
- Ubiquitin-activating enzyme E1, FCCH domain superfamily
- Ubiquitin-activating enzyme E1, inactive adenylation domain, subdomain 1
- ThiF/MoeB/HesA family
- ThiF family
- Ubiquitin fold domain
- Ubiquitin-activating enzyme, SCCH domain
- Ubiquitin-activating enzyme E1 FCCH domain
- Ubiquitin-activating enzyme E1 four-helix bundle
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of UBA6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads UBA6 as an antibody target. Whether an autoantibody or antibody against UBA6 could matter depends on whether native UBA6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
UBA6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label UBA6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...